Passage Bio, Inc. Insider Transactions
Passage Bio, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Lynx1 Capital Management LP
10 percent owner |
Buy | 373,645 @ $0.65 | $241.04 K | 9,256,953 | 12/27/2024 | 12/31/2024 | |
|
ORBIMED ADVISORS LLC
10 percent owner |
Sell | 230,321 @ $0.60 | $138.19 K | 7,404,869 | 12/20/2024 | 12/26/2024 | |
|
ORBIMED ADVISORS LLC
10 percent owner |
Sell | 80 @ $0.80 | $64 | 7,635,190 | 12/11/2024 | 12/11/2024 | |
|
ORBIMED ADVISORS LLC
10 percent owner |
Sell | 8,015 @ $0.80 | $6.41 K | 7,635,270 | 12/10/2024 | 12/11/2024 | |
|
ORBIMED ADVISORS LLC
10 percent owner |
Sell | 54,181 @ $0.84 | $45.51 K | 7,643,285 | 12/09/2024 | 12/11/2024 | |
|
ORBIMED ADVISORS LLC
10 percent owner |
Sell | 20,903 @ $0.82 | $17.14 K | 7,697,466 | 12/06/2024 | 12/06/2024 | |
|
ORBIMED ADVISORS LLC
10 percent owner |
Sell | 76,200 @ $0.79 | $60.20 K | 7,718,369 | 12/04/2024 | 12/06/2024 | |
|
Lynx1 Capital Management LP
10 percent owner |
Buy | 29,300 @ $0.67 | $19.66 K | 8,883,308 | 11/27/2024 | 11/27/2024 | |
|
Lynx1 Capital Management LP
10 percent owner |
Buy | 167,055 @ $0.71 | $118.19 K | 8,854,008 | 11/26/2024 | 11/27/2024 | |
|
Lynx1 Capital Management LP
10 percent owner |
Buy | 259,998 @ $0.56 | $146.67 K | 8,686,953 | 11/25/2024 | 11/27/2024 | |
|
ORBIMED ADVISORS LLC
10 percent owner |
Sell | 39,300 @ $0.71 | $27.90 K | 7,794,569 | 09/19/2024 | 09/23/2024 | |
|
ORBIMED ADVISORS LLC
10 percent owner |
Sell | 25,631 @ $0.73 | $18.71 K | 7,833,869 | 09/18/2024 | 09/18/2024 | |
|
ORBIMED ADVISORS LLC
10 percent owner |
Sell | 111,400 @ $0.73 | $81.32 K | 7,859,500 | 09/17/2024 | 09/18/2024 | |
|
ORBIMED ADVISORS LLC
10 percent owner |
Sell | 63,100 @ $0.74 | $46.69 K | 7,970,900 | 09/16/2024 | 09/18/2024 | |
|
Borthwick Kathleen
SVP, INTERIM CFO |
Sell | 1,470 @ $0.97 | $1.43 K | 28,466 | 02/13/2024 | 02/13/2024 | |
|
Forman Mark S
CHIEF MEDICAL OFFICER |
Sell | 1,638 @ $0.97 | $1.59 K | 48,631 | 02/13/2024 | 02/13/2024 | |
|
Forman Mark S
Chief Medical Officer |
Sell | 15,813 @ $0.91 | $14.39 K | 45,269 | 01/02/2024 | 01/03/2024 | |
|
Borthwick Kathleen
SVP, Interim CFO |
Sell | 10,672 @ $0.91 | $9.71 K | 25,936 | 01/02/2024 | 01/03/2024 | |
|
Cale Edgar B.
GC & Corporate Secretary |
Sell | 15,813 @ $0.91 | $14.39 K | 45,995 | 01/02/2024 | 01/03/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Passage Bio, Inc. FAQ's
The list of insiders at Passage Bio, Inc. includes ORBIMED ADVISORS LLC, Lynx1 Capital Management LP, Borthwick Kathleen.
Insiders have sold a total of 1.70 M Passage Bio, Inc. shares in the last 12 months for a total of 794.38 K sold.
The following insiders have sold Passage Bio, Inc. shares in the last 12 months: ORBIMED ADVISORS LLC ($792.69 K), Borthwick Kathleen ($1.69 K),
Insiders have purchased a total of 502.49 K Passage Bio, Inc. shares in the last 12 months for a total of 974.86 K.
The following insiders have purchased Passage Bio, Inc. shares in the last 12 months: Lynx1 Capital Management LP ($974.86 K),